DERM
Journey Medical Corp
Key Financials
Net Income
$-11431000
↑ 22.1%
Revenue
$61.9M
↑ 10.2%
Operating Income
$-8172000
↑ 40.3%
EPS (Diluted)
$-0.47
↑ 34.7%
Shareholders' Equity
$31.9M
↑ 58.7%
Cash & Equivalents
$24.1M
↑ 18.6%
Total Assets
$94.6M
↑ 17.9%
Total Liabilities
$62.7M
↑ 4.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/12/2026 | View on SEC |
| 8-K | 8/12/2026 | View on SEC |
| SCHEDULE 13G/A | 7/31/2026 | View on SEC |
| SCHEDULE 13G/A | 7/15/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 6/29/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DERM |
| Company Name | Journey Medical Corp |
| CIK | 1867066 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 480-434-6670 |